Navigation Links
Special Stockholders Meeting to Elect Directors Set for March 4, 2008
Date:1/22/2008

OLDSMAR, Fla., Jan. 22 /PRNewswire-FirstCall/ -- The Delaware Court of Chancery today issued its Order and Final Judgment in a case brought by a stockholder of Cryo-Cell International Inc. (OTC Bulletin Board: CCEL) challenging the election results of the annual meeting of stockholders held on July 16, 2007. The court ordered the Company to hold a new election of directors at a special stockholders meeting to be held on March 4, 2008, commencing at 3:00 p.m., EST. The record date for the purpose of determining stockholders entitled to notice of and to vote at the special meeting is January 18, 2008. The directors who sat on the Cryo-Cell Board of Directors prior to the 2007 annual meeting will continue in office until the special meeting of stockholders is held.

The Company will provide additional information about the meeting when it is available.

About Cryo-Cell International Inc.

Based in Oldsmar, Florida, with over 140,000 clients worldwide, Cryo-Cell is one of the largest and most established family cord blood banks. ISO 9001:2000 certified and accredited by the AABB, Cryo-Cell operates in a state-of-the-art Good Manufacturing Practice and Good Tissue Practice (cGMP/cGTP)-compliant facility. Cryo-Cell is a publicly traded company. OTC Bulletin Board Symbol: CCEL. For more information, please call 1-800-STOR-CELL (1-800-786-7235) or visit http://www.cryo-cell.com.

Cryo-Cell expects to file a proxy statement with the Securities and Exchange Commission and to send the proxy statement to shareholders in connection with this special meeting to elect directors. The Company urges investors and stockholders to read the proxy statement carefully when it is available. The proxy statement will contain important information about the proposals to be brought before the annual meeting. Investors and shareholders will be able to obtain free copies of the proxy statement, once available, as well as other filings made by the Company with the Commission, through the Web site maintained by the Commission at http://www.sec.gov. Free copies of the proxy statement, once available, may also be obtained by stockholders by directing a request to the Company at: Cryo-Cell International, Inc., 700 Brooker Creek Blvd., Suite 1800, Oldsmar, Florida 34677, Attention: Corporate Secretary.

Cryo-Cell, its directors, executive officers and certain other members of management and employees may be soliciting proxies from the Company's stockholders in connection with the special meeting. Information concerning the Company is set forth in its filings with the Commission and information regarding other possible participants in the solicitation is set forth in the Company's proxy statement filed by the Company with the Commission on June 8, 2007.

Contact:

Jill Taymans, Chief Financial Officer

Phone: 813-749-2104

E-mail: jtaymans@cryo-cell.com


'/>"/>
SOURCE Cryo-Cell International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Wedgewood Pharmacy Will Continue to Provide Avastin(R) to Ophthalmologists and Retinal Specialists
2. Georgia Reproductive Specialists is First in Southeast to Offer Pioneering Test of Womens Biological Clock
3. Agennix Receives Special Protocol Assessment Approval from FDA for the Pivotal Trial of Talactoferrin Alfa in First-Line Non-Small Cell Lung Cancer
4. ASH Holds a Special Symposium to Interest High School Students in Biomedical Research
5. ThromboGenics Presents Results of the Vitreomacular Traction Trial (MIVI IIT) at the American Society of Retina Specialists Annual Meeting
6. Delivering Molecular Imaging Solutions Across Clinical Specialties: Siemens Showcases New Technologies at RSNA 2007
7. Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy
8. IsoTis Adjourns Special Meeting to October 29, 2007
9. Varian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About Cancer
10. Specialists in infectious disease and global health convene at Philadelphia meeting
11. IsoTis Adjourns Special Meeting to October 26, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2017)... ROCKVILLE, Md. , Aug. 11, 2017 ... in a New York Times article regarding ... 9.2 billion, according to Kalorama Information.  The ... an App for That"  used information ... Remote Patient Monitoring & Telemedicine Market  (Sleep, ...
(Date:8/10/2017)... (PRWEB) , ... August 09, 2017 , ... ... the classroom next week-- as students. From August 14th through the 16th, the ... institute, which debuted in the summer of 2016, provides Philadelphia-based middle school educators ...
(Date:8/10/2017)... ... August 10, 2017 , ... DrugDev and ... webinar to demonstrate how Good Clinical Practice (GCP) can be used throughout ... addition the webinar will discuss the importance of GCP compliance, how sites are affected ...
(Date:8/8/2017)... ... August 08, 2017 , ... HumanZyme ... in human cells, today announced the launch of HumanKine® Interferon beta ... I family of interferons that activate Th1-type innate immune responses against viral and bacterial ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
Breaking Biology News(10 mins):